Skip to main content
Log in

Development and Validation of Different Chromatographic Methods for Analysis of Cabergoline in the Presence of Its Degradation Products: Studying Degradation Profile

  • Original
  • Published:
Chromatographia Aims and scope Submit manuscript

Abstract

Cabergoline is widely used as a prolactin secretion inhibitor and as a treatment for Parkinson’s disease. Studying the structure of cabergoline, it contains a urea moiety and an amide group which are sensitive to degradation by hydrolysis as well as an alkene bond that is susceptible to oxidation. Degradation was performed regarding ICH recommendations including hydrolysis (pH from 1.3 to 12.7 using HCl or NaOH with different molarities), oxidation, photo, and thermal degradations. The drug was highly sensitive to all studied conditions except thermal degradation with the production of three major degradation products which were isolated and identified using IR and MS analyses. Two stability indicating chromatographic methods were developed for quantification of the drug in the presence of its degradation products. The first method was HPTLC which depended on using a developing system of butanol:methanol:triethyl amine (95:5:10, by volume) and UV scanning at 280 nm. The second method was HPLC at which the drug and degradation products were separated within 5 min using acetonitrile: 0.05% aqueous triethylamine (TEA) (pH adjusted to 6.5 using 1% aqueous H3PO4) [70:30, v/v] and UV scanning was performed at 225 nm. Validation parameters were calculated according to ICH recommendations and all parameters were within the acceptable limits. Comparison was made between the developed methods and the previously published ones; the developed methods were found to be superior regarding analysis time, studying different degradation pathways, and identifying the degradation products.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. British Pharmacopoeia (2012) Her Majesty’s stationary office. Electronic Version, London

    Google Scholar 

  2. The United States Pharmacopeia (2012) National formulary 35, 30th edn. United States Pharmacopeia Convention Inc., New York

    Google Scholar 

  3. Budavari S (2006) The Merck index, 14th edn. Merck and Co Inc., Whitehouse Station

    Google Scholar 

  4. Martindale-Extra Pharmacopoeia (2005) The complete drug references, 34th edn. The pharmaceutical Press, London

    Google Scholar 

  5. Salman D, Dogan A, Basci NE (2011) Spectrophotometric analysis of cabergoline in pharmaceutical preparations. Latin Am J Pharm 30:304–310

    CAS  Google Scholar 

  6. Onal A, Cağlar S (2007) Spectrophotometric determination of dopaminergic drugs used for Parkinson’s disease, cabergoline and ropinirole in pharmaceutical preparations. Chem Pharm Bull 55(4):629–631

    Article  CAS  PubMed  Google Scholar 

  7. Rambabu C, Jyothirmayee CA, Raju KN (2012) Spectrophotometric determination of cabergoline in tablet dosage forms. Int J Pharm Chem Biolog Sci (IJPCBS) 2(1):72–77

    CAS  Google Scholar 

  8. Rambabu C, Jyothirmayee CA, Raju KN (2012) Spectrophotometric determination of cabergoline in tablet dosage forms. Asian J Res Chem 5(2):279–281

    Google Scholar 

  9. Rambabu C, Jyothirmayee CA, Raju KN (2012) Spectrophotometric determination of cabergoline in tablet dosage form. Int J Pharm Chem Biol Sci 2(1):72–77

    CAS  Google Scholar 

  10. Jyothirmayee CA, Raju KN (2014) RP-HPLC method for the estimation of cabergoline in pharmaceutical formulations. Int J Res Pharm Chem 4(4):977–981

    CAS  Google Scholar 

  11. Magnes C, Suppan M, Thomas R (2008) Validated comprehensive analytical method for quantification of cabergoline by LC/MS/MS. Anal Chem 80(15):5736–5742

    Article  CAS  PubMed  Google Scholar 

  12. Kimball BA, DeLiberto TJ, Johnston JJ (2001) Determination of cabergoline by electrospray ionization tandem mass spectrometry: picogram detection via column focusing sample introduction. Anal Chem 73:4972–4976

    Article  CAS  PubMed  Google Scholar 

  13. Lasan VM, Indrekar TD (2016) Development and validation of stability indicating analytical method for the determination of cabergoline. Int J Pharm Res Sch (IJPRS) 5(1–2):141–150

    CAS  Google Scholar 

  14. Ӧnal A, Sagırlı O, Sensory D (2007) Selective LC determination of cabergoline in the bulk drug and in tablets: in vitro dissolution studies. Chromatographia 65:561–567

    Article  CAS  Google Scholar 

  15. Athak AP, Rajput SJ (2009) Development of a stability indicating HPLC method for simultaneous determination of olanzapine and fluoxetine in combined dosage forms. J Chromatogr Sci 47:605–611

    Article  Google Scholar 

  16. Darwish IA, Askal HF, Khedr AS, Mahmoud RM (2008) Stability indicating TLC method for quantitative determination of rebaverine. J Chromatogr Sci 46:5–11

    Article  Google Scholar 

  17. Abiramasundair A, Joshi RP, Jalani HB, Sharma JA, Pandya DH, Pandya AN, Sudarsanam V, Vasu KK (2014) Stability-indicating assay method for determination of actarit, its process related impurities and degradation products: insight into stability profile and degradation pathways. J Pharm Anal 4:374–383

    Article  CAS  Google Scholar 

  18. Abdelwahab NS, Farid NF (2014) Validated HPLC-DAD method for stability study of sulbutiamine HCl. RSC Adv 4:30523–30529

    Article  CAS  Google Scholar 

  19. Sreenivasa PR, Uttam KR, Hiriyanna SG, Sumathi VR, Mukkanti K (2011) Identification of oxidative degradation impurities of olanzapine drug substance as well as drug product. J Pharm Biomed Anal 56:413–418

    Article  CAS  Google Scholar 

  20. Sabry SM, Belal TS, Barary MH, Ibrahim MEA (2013) A validated HPLC method for the simultaneous determination of naftidrofuryl oxalate and its degradation product (metabolite), naftidrofuryl acid: applications to pharmaceutical tablets and biological samples. Drug Test Anal 5:500–508

    Article  CAS  PubMed  Google Scholar 

  21. Jafari-Nodoushan M, Barzin J, Mobedi H (2016) A stability-indicating HPLC method for simultaneous determination of morphine and naltrexone. J Chromatogr B 1011:163–170

    Article  CAS  Google Scholar 

  22. Emam AA (2018) Canagliflozin stability study and ecofriendly chromatographic determination of its degradation product: a comparative study. J Sep Sci 41:822–830

    Article  CAS  PubMed  Google Scholar 

  23. ICH, Harmonized Tripartite Guidelines (2003) Stability testing of new drug substances and products. Q1A (R2): International conference on harmonization, IFPMA, Geneva, pp 1–18

  24. Through website: http://www.toxipedia.org/display/toxipedia/Chloroform. Accessed 29 Dec 2018

  25. Through website: https://owlcation.com/stem/Chloroform-in-the-Environment-and-its-Dangers. Accessed 29 Dec 2018

  26. Sarmah AK, Sabadie J (2002) Hydrolysis of sulfonylurea herbicides in soils and aqueous solutions: a review. J Agric Food Chem 50:6253–6265

    Article  CAS  PubMed  Google Scholar 

  27. Bansal G, Singh M, Jindal KC, Singh S (2008) LC and LC-MS study on establishment of degradation pathway of glipizide under forced decomposition conditions. J Chromatogr Sci 46:510–517

    Article  CAS  PubMed  Google Scholar 

  28. Carl RK, Mark JL (2007) Amide resonance correlates with a breadth of C–N rotation barriers. J Am Chem Soc 129(9):2521–2528

    Article  CAS  Google Scholar 

  29. Kovaříková P, Klimeš J, Dohnal J, Tisovská L (2004) HPLC study of glimepiride under hydrolytic stress conditions. J Pharm Biomed Anal 36:205–209

    Article  CAS  PubMed  Google Scholar 

  30. Abdelwahab NS, Elsaady MT, Korany AG, Hegazy MA (2017) Study of gliquidone degradation behavior by high performance thin-layer chromatography and ultra performance liquid chromatography methods. Biomed Chromatogr 31:4025–4035

    Article  CAS  Google Scholar 

  31. Through website: https://chem.libretexts.org/Courses/Sacramento_City_College/SCC%3A_Chem_420_Organic_Chemistry_I/Text/09%3A_Reactions_of_Alkenes/9.12%3A_Oxidation_of_Alkenes_-_Epoxidation. Accessed 22 May 2019

  32. International Conference on Harmonisation (ICH) (2005) Validation of analytical procedures: text and methodology Q2(R1). ICH, pp 1–13

  33. Srivastava MM (2011) High performance thin layer chromatography (HPTLC). Springer, Heidelberg, pp 33–38

    Book  Google Scholar 

Download references

Acknowledgements

The authors express their appreciation and would like to thank Dr. Asmaa Mohamed Aboul Magd, Pharmaceutical Chemistry Department, Nahda University (NUB), Beni-Suef, Egypt, for his effort in elucidation of the chemical structure of the degradation products.

Funding

This work is not funded.

Author information

Authors and Affiliations

Authors

Contributions

Both Dr. NFF and Dr. NSA did the practical work and wrote the manuscript.

Corresponding author

Correspondence to Nada Sayed Abdelwahab.

Ethics declarations

Conflict of interest

Nehal Fayek Farid declares that she has no conflict of interest. Nada Sayed Abdelwahab declares that she has no conflict of interest.

Research involving human participants and/or animals

No human volunteers or animals were used in this work.

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Farid, N.F., Abdelwahab, N.S. Development and Validation of Different Chromatographic Methods for Analysis of Cabergoline in the Presence of Its Degradation Products: Studying Degradation Profile. Chromatographia 82, 1555–1569 (2019). https://doi.org/10.1007/s10337-019-03763-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10337-019-03763-4

Keywords

Navigation